What is the clinical and cost effectiveness of biomarker-based monitoring, monitoring with cardiac MRI, and monitoring with repeated echocardiography in people with heart failure?
The aim of this review was to examine the clinical and cost-effectiveness of biomarker measurement or imaging in the management of patients with HF. Evidence-based treatments for heart failure have been found to reduce hospital admissions and increase survival, particularly for patients with HFREF. Objective tests such as biomarker measurement and imaging can potentially inform management decisions, optimise treatment, and improve effectiveness and cost-effectiveness for individuals with heart failure. However, more research is needed to better understand the clinical and cost-effectiveness of these tests in the management of heart failure.